 Record date **PHI** Team 2 Internal Medicine Intern Admission Note Name **PHI** , **PHI** MR # **PHI** Admit Date **PHIDate** Attending Dr. **PHI** Admitting intern **PHI** **PHI** , MD Code Full Source Medical record , Patient Chief Complaint fistula clot History of Present Illness Pt is a 59 yo **PHI** male , with h o HTN , DM , mucormycosis , and ESRD on HD presenting with a thrombosed AVF in his left arm , established in **PHI** of **PHI** by Dr. **PHI** . The patient has a history of multiple problems with access ( clots , stenoses ), requiring frequent thrombectomies and revisions . The patient first noticed a problem on **PHI** **PHI** , and by the 24th he said that `` the access had collapsed . '' On **PHI** **PHI** , interventional radiology attempted to thrombectomize the clot , with no success , requiring placement of a new tunneled catheter in left **PHI** to allow dialysis . At present , patient is on the OR waiting list for tomorrow , for thrombectomy revision . Of note , patient was admitted in **PHI** of **PHI** after a nurse at the **PHI** Hospital detected a new cardiac murmur . Pt was found to have a RA thrombus by echo , presumed to be a complication from a prior catheter , started on a heparin gtt and transitioned to coumadin . ROS No fever chills , HA , SOB , CP , N V D ( though states that stomach sometimes `` sensitive ''). Past Medical History DM Type 2 HTN ESRD on HD MWF , with h o multiple problems with access , Cr baseline 4 s p extensive bowel resection for mucormycosis , **PHI** **PHI** ( gastrectomy , esophagojejunostomy , splenectomy , distal pancreatectomy , segmental transverse colectomy ) s p L THR s p resection arthroplasty of left femoral head and acetabulum for fungal infection ( **PHI** above , **PHI** **PHI** ) R atrial thrombus by echo in **PHIDate** Allergies **PHI** rash Penicillin rash Medications ( upon admission ) **PHI** ( MIRTAZAPINE ) 15 MG ( 15MG TABLET take 1 ) PO **PHI** Nexium ( ESOMEPRAZOLE ) **PHI** **PHI** **PHI** **PHI** **PHI** DR take 1 ) PO QD TRAZODONE 50 MG ( 50MG TABLET take 1 ) PO **PHI** Colace ( DOCUSATE Sodium ) 100 MG ( 100MG TABLET take 1 ) PO TID Norvasc ( AMLODIPINE ) 10 MG ( 10MG TABLET take 1 ) PO QD Diovan ( VALSARTAN ) 80 MG ( 80MG TABLET take 1 ) PO QD Insulin Regular Human SC NEPHROCAPS 1 CAPSULE PO QD Renagel ( SEVELAMER ) 806 MG ( 403MG CAPSULE take 2 ) PO TID Folate ( FOLIC Acid ) 1 MG ( 1MG TABLET take 1 ) PO QD Calcium Carbonate ( 500 Mg Elemental Ca++) 1250 MG PO **PHI** Warfarin Sodium 2.5 MG ( 2.5MG TABLET take 1 ) PO QPM Social History Patient is a native of Kazakhstan , who moved to the UKRAINE to study Electrical Mechanics at **PHI** Inc . He is currently unable to pursue this field , due to his debilitated state , however he would like to try to intern , when he feels up to it . He lives in the **PHI** Hospital in **PHI** ( a facility for homeless individuals .) No tobacco , EtOH , illicits . Family History Non contributory . Exam Vitals BP 121 62 HR 78 RR 16 T 97.5 O2 sat 100 % RA Gen HEENT **PHI** , OP without erythema , exudates ; mucous membranes moist ; no scleral icterus Pulm CTA with good air movement bilat . ; no c w r Cor Cardiac RRR nl . S1 , S2 ; no m g r , neck veins flat Abdomen S NT ND ; +BS throughout ; no HSM , palpable pulsatile masses Extremity no c c e ; distal pulses 2+ bilat ; left LE shorter than right and internally rotated Neurological CN II **PHI** grossly intact , strength **PHIDate** all major muscle groups ; DTR 's 2+ bilat . UE LE , Laboratory Hematology EDUCARE PULLMAN BLOOD **PHIDate** 16 10 Accession # **PHI** WBC 8.0 ( 4.5 11.0 ) th cmm HCT 34.7 L ( 41.0 53.0 )% HGB 11.0 L ( **PHI** ) gm dl RBC 3.55 L ( 4.50 5.90 ) mil cmm PLT 255 ( 150 350 ) th cumm MCV 98 ( 80 100 ) fl MCH 31.1 ( 26.0 34.0 ) pg rbc MCHC 31.8 ( 31.0 37.0 ) g dl **PHI** 15.3 H ( **PHI** )% Retic 2.6 H ( 0.5 2.5 )% **PHI** EDUCARE PULLMAN BLOOD **PHIDate** 16 10 Accession # **PHI** **PHI** **PHI** 135 ( 135 145 ) mmol**PHI** **PHI**  Potassium 5.0 H ( 3.4 4.8 ) mmol**PHI** **PHI**  Chloride 100 ( 100 108 ) mmol**PHI** **PHI**  **PHI** Dioxide 19.4 L ( 23.0 31.9 ) mmol L Calcium 7.7 L ( 8.5 10.5 ) mg dl Phosphorus 5.3 H ( 2.6 4.5 ) mg dl **PHI** Urea Nitrogen 74 H ( 8 25 ) mg dl **PHI** Creatinine 7.7 H ( 0.6 1.5 ) mg dl **PHI** **PHI** 113 H ( 70 110 ) mg dl Albumin 3.7 ( 3.3 5.0 ) g dl **PHI** Hormone 187 H ( 10 60 ) pg ml EKG NSR at 75 80 , normal axis , normal intervals . **PHI** ST changes or **PHI** compared to prior in **PHI** **PHI** ( J point elevation in V1 V3 in both ). Cardiac Studies Echo **PHIDate** EF 65 %, LVH , mobile mass ( 27x22mm ) in RA , small pericardial effusion . Radiology CXR **PHI** **PHI** , **PHI** IMPRESSION Dual lumen dialysis catheter from the left jugular region to the right atrium without pneumothorax , hematoma , or pleural effusion . No new or enlarging infiltrates or masses . Slight fullness in the region of the right thyroid gland . Assessment and Plan 59 yo **PHI** male , with HTN , DM , and ESRD on HD , and h o access issues ( multiple thromboses , stenoses requiring frequent revisions ) and admitted with clotted left AVF for revision thrombectomy in the OR . 1 . Access clotted L AVF , functional left **PHI** tunneled cath . a . On waiting list with Dr. **PHI** for procedure tomorrow i. NPO p MN ii . Hold coumadin b. IV access for R arm . 2 . ESRD on HD a . Patient for dialysis on Monday , if still inpatient . b. **PHI** nephrocaps , renagel , **PHI** , 3 . DM Pt reports well controlled , rarely c FS > 200 a. FS qam , qpm before breakfast and dinner ; reg ins sliding scale b. Diabetic diet 4 . HTN a . Continue outpatient regimen of norvasc and diovan b . Note these meds are held on dialysis days ( MWF ) 5. h o R atrial clot a. INR goal 1.8 2.5 b . Consider repeat echo , to evaluate clot stabilization and to better plan anticoagulation regimen c. Follow coags 6 . Elevated K to 5.8 5.0 on **PHIDate** . a . Check pm labs , assess need for kayexalate . 7 . Low Hct ( lowest since **PHIDate** ) a . Anemia panel 8 . Prophylaxis a. Nexium , on coumadin tx ( though held tonight ) 9 . Code status full code **PHI** **PHI** , MD Team 2 intern # **PHI**